Karnofsky Performance Status assessment: Resident versus attending

Journal of Cancer Education

Volumn 17, Issue 3, 2002, Pages 138-141

  Liem, Benny J ^a   Holland, John M ^a   Kang, Matt Y ^a   Hoffelt, S Christopher ^a   Marquez, Carol M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CORRELATION COEFFICIENT; HUMAN; MAJOR CLINICAL STUDY; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; RESIDENT; SCORING SYSTEM;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL COMPETENCE; EVALUATION STUDIES; FEMALE; HUMANS; INTERNSHIP AND RESIDENCY; KARNOFSKY PERFORMANCE STATUS; MALE; MEDICAL STAFF, HOSPITAL; MIDDLE AGED; PATIENT SIMULATION; RADIATION ONCOLOGY; RADIOTHERAPY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0036739801     PISSN: 08858195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In:Macleod CM (ed). Evaluation of Chemotherapeutic Agents. New York: Columbia University Press, 1949: 191-205.
2. Karnofsky DA, Abelmann WH, Craver LF, et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer. 1948;1:634-56.
3. Hutchinson TA, Boyd NF, Feinstein AR. Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis. 1979;32:661-6.
4. Schag CC, Heinrich RL, Ganz PA. Karnofsky Performance Status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984; 2:187-93.
5. Slevin ML, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988;57:109-12.
6. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer. 1980;45:2220-4.
7. Grieco A, Long CJ. Investigation of the Karnofsky Performance Status as a measure of quality of life. Health Psychol. 1984;3:129-42.
8. Mor V, Laliberte L, Morris JN, et al. The Karnofsky Performance Status scale-an examination of its reliability and validity in a research setting. Cancer. 1984;53:2002-7.
9. Conill C, Verger E, Salamero M. Performance status assessment in cancer patients. Cancer. 1990;65:1864-6.
10. Maurer LH, Pajak TF. Prognostic factors in small cell carcinoma of the lung: A Cancer and Leukemia Group B study. Cancer Treat Rep. 1981;65:767-74.
11. Reed R, Livingstone R. Prognostic significance of pretreatment variables in small cell carcinoma of the lung. Proceedings of the American Society of Clinical Oncology. 1977;18:307.
12. Holoye PY, Samuels ML. Cyclophosphamide, vincristine and sequential split course radiotherapy in the treatment of small cell lung cancer. Chest. 1975;67:675-8.
13. Holoye PY, Samuels ML, Lanzotti VJ, et al. Combination chemotherapy and radiation therapy for small cell carcinoma. JAMA. 1977;237:1221-4.
14. Lagkos SW. Prognostic factors for survival time in inoperable lung cancer. In: Strauss MJ (ed). Lung Cancer. New York: Grune & Stratton, 1977: 271-80.
15. Livingston RB, Moore TN, Heilbrun L, et al. Small cell carcinoma of the lung: combined chemotherapy and radiation. Ann Intern Med. 1978;88:194-9.
16. Trauth CJ, Livingston RB, Moore TN. Response and survival update in combined modality treatment of small cell carcinoma of the lung. Proceedings of the American Society of Clinical Oncology. 1978; 19:405.
17. Yates JW, McKegney FP, Kun LE. A comparative study of home nursing care of patients with advanced cancer. In: American Cancer Society. Proceedings of the American Cancer Society's National Conference on Human Values and Cancer. 1980: 207-18.
18. Gutman RA, Stead WW, Robinson RR. Physical activity and employment status of patients on maintenance dialysis. N Engl J Med. 1981;304:309-13.